Claire Mazumdar, Chief Executive Officer at Bicara Therapeutics Inc. (BCAX), sold 10,000 shares at $28.42 ($284K) on 2026-07-10, disclosed to the SEC on 2026-07-14.
Scheduled sale ($284k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.42 | 9,972 | $283K | 99.7% |
| 2 | $29.68 | 28 | $831 | 0.3% |
| Total | $28.42 avg | 10,000 | $284K | 100% |
| Filing → |
| BCAX | SELL | 2026-04-20 | $354K | — | Filing → |
| BCAX | SELL | 2026-03-20 | $565K | — | Filing → |
| BCAX | SELL | 2026-03-11 | $1.4M | — | Filing → |